Vanguard Asset Management
FOLD

Vanguard Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Asset Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-256,224
Closed -$3.7M – 2463
2026
Q1 		$3.7M Buy
+256,224
New +$3.67M ﹤0.01% 1114

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Vanguard Asset Management's FOLD Position: Q2 2026 in Review

Vanguard Asset Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 256,224 shares — an estimated $3.7M sold.

Vanguard Asset Management first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $3.7M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Vanguard Asset Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Vanguard Asset Management sold 256,224 Amicus Therapeutics shares in Q2 2026, an estimated $3.7M.
  • Vanguard Asset Management first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Vanguard Asset Management's Amicus Therapeutics position peaked at $3.7M in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Vanguard Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.